Last updated on November 2017

FOURIER - Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Dyslipidemia
  • Age: Between 40 - 85 Years
  • Gender: Male or Female
  • Other:

    Inclusion Criteria:

    • Male or female ≥ 40 to ≤ 85 years of age

    • History of clinically evident cardiovascular disease at high risk for a recurrent event

    • Fasting LDL-C ≥ 70 mg/dL (≥ 1.8 mmol/L) ) or non-HDL-C ≥ 100 mg/dL (> 2.6 mmol/L)

    • Fasting triglycerides ≤ 400 mg/dL (4.5 mmol/L)

    Exclusion Criteria

    • NYHA class III or IV, or last know left ventricular ejection fraction <30%

    • Uncontrolled hypertension

    • Uncontrolled or recurrent ventricular tachycardia

    • Untreated hyperthyroidism or hypothyroidism

    • Homozygous familial hypercholesterolemia

    • LDL or plasma apheresis

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.